Imatinib Fresenius Kabi 400 mg film-coat. tabl.

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Imatinib Mesilate 478 mg - Eq. Imatinib 400 mg

Available from:

Fresenius Kabi Deutschland GmbH

ATC code:

L01XE01

INN (International Name):

Imatinib Mesilate

Dosage:

400 mg

Pharmaceutical form:

Film-coated tablet

Composition:

Imatinib Mesilate 478 mg

Administration route:

Oral use

Therapeutic area:

Imatinib

Product summary:

CTI code: 494684-06 - Pack size: 120 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 494684-07 - Pack size: 180 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 494684-01 - Pack size: 10 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 494684-02 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 494684-03 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 494684-04 - Pack size: 60 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 494684-05 - Pack size: 90 - Commercialisation status: NO - Delivery mode: Medical prescription

Authorization status:

Commercialised: No

Authorization date:

2016-04-13